血清PIVKA-II、AFP与HBV-DNA联合检测对HBV所致肝癌的诊断及预后预测价值

万强, 赵波, 王瑶瑶

PDF(1134 KB)
欢迎访问《标记免疫分析与临床》官方网站!
PDF(1134 KB)
标记免疫分析与临床 ›› 2024, Vol. 31 ›› Issue (4) : 685-691. DOI: 10.11748/bjmy.issn.1006-1703.2024.04.019
临床研究

血清PIVKA-II、AFP与HBV-DNA联合检测对HBV所致肝癌的诊断及预后预测价值

    {{javascript:window.custom_author_cn_index=0;}}
  • {{article.zuoZhe_CN}}
作者信息 +

The Value of Combined Detection of Serum PIVKA-II,AFP and HBV-DNA in the Diagnosis and Prognosis Prediction of HBV-induced Liver Cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

本文亮点

{{article.keyPoints_cn}}

HeighLight

{{article.keyPoints_en}}

摘要

{{article.zhaiyao_cn}}

Abstract

{{article.zhaiyao_en}}

关键词

Key words

引用本文

导出引用
{{article.zuoZheCn_L}}. {{article.title_cn}}. {{journal.qiKanMingCheng_CN}}. 2024, 31(4): 685-691 https://doi.org/10.11748/bjmy.issn.1006-1703.2024.04.019
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 31(4): 685-691 https://doi.org/10.11748/bjmy.issn.1006-1703.2024.04.019

参考文献

参考文献

{{article.reference}}

基金

版权

{{article.copyrightStatement_cn}}
{{article.copyrightLicense_cn}}
PDF(1134 KB)

Accesses

Citation

Detail

段落导航
相关文章

/